NIH Funding Opportunities and Notices for 05-10-2019 (The NIH Guide TOC)

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts May 10, 2019  (Web Version)

General Notices Notice of Availability of Administrative Supplements to NIBIB C3i Participants for Advancing Innovation (NOT-EB-19-013) `  and Suggestions on the Potential Development of a Challenge Prize for Heart Failure Phenotyping" (NOT-HL-19-701) National Heart, Lung, and Blood Institute HHS issues Four (4) PHS 2019-2 SBIR and STTR Omnibus/Parent Grant Solicitations (NOT-OD-19-105) National Institutes of Health Notice of Changes to Funding Opportunities Notice of Additional Application Requirements for PA-18-823  (NOT-AG-19-022) National Institute on Aging Notice to Extend the Expiration Date of PAR-16-413: NIAID Investigator Initiated Program Project Applications (P01) (NOT-AI-19-058) National Institute of Allergy and Infectious Diseases Notice of Clarification to RFA-NS-18-043, "Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)" (NOT-AT-19-024) National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke Notice of Clarification to RFA-NS-18-042, "Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed)" (NOT-AT-19-026) National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke Notice of Participation of NCI in PAR-19-156 "Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed)" and PAR-19-157 "Bioengineering Research Partnerships (U01 Clinical Trial Required)" (NOT-CA-19-049) National Cancer Institute Notice of Correction to Eligibility Information in PAR-18-466, The NCI Transition Career Development Award (K22 Independent Clinical Trial Required) (NOT-CA-19-050) National Cancer Institute Notice of Correction to Eligibility Information in PAR-18-467, The NCI Transition Career Development Award (K22 Independent Clinical Trial Not Allowed) (NOT-CA-19-051) National Cancer Institute Notice to Extend the Expiration Date of PAR-18-062 "Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)" (NOT-DA-19-034) National Institute on Drug Abuse National Institute on Alcohol Abuse and Alcoholism Notice of Correction to PAR-19-246 "Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed)" (NOT-DA-19-040) National Institute on Drug Abuse Notice of NICHD's Participation in PA-19-065, "Medical Simulators for Practicing Patient Care Providers Skill Acquisition, Outcomes Assessment and Technology Development (R01 Clinical Trial Not Allowed)" (NOT-HD-19-015) Eunice Kennedy Shriver National Institute of Child Health and Human Development Notice to Extend the Expiration Date for PA-18-141 "Mechanisms, Models, Measurement, & Management in Pain Research (R01 Clinical Trial Optional)" (NOT-NS-19-061) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Cancer Institute National Institute on Aging National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute on Minority Health and Health Disparities National Institute of Nursing Research Notice to Extend the Expiration Date for PA-18-159 "Mechanisms, Models, Measurement, & Management in Pain Research (R21 Clinical Trial Optional)" (NOT-NS-19-062) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Cancer Institute National Institute on Aging National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute on Minority Health and Health Disparities National Institute of Nursing Research Notice to Extend the Expiration Date for PAR-18-711 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)" (NOT-NS-19-063) National Institute of Neurological Disorders and Stroke Notice to Extend the Expiration Date for PAR-18-710 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)" (NOT-NS-19-065) National Institute of Neurological Disorders and Stroke Notice to Extend the Response Date for NOT-RM-19-001 Request for Information (RFI): Institutional Accountability to Promote Inclusive Excellence (NOT-RM-19-008) Office of Strategic Coordination (Common Fund) Notices of Intent to Publish Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trial Not Allowed) (NOT-EB-19-010) National Institute of Biomedical Imaging and Bioengineering National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health National Institute of Neurological Disorders and Stroke Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01 Clinical Trial not allowed) (NOT-EB-19-011) National Institute of Biomedical Imaging and Bioengineering National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health National Institute of Neurological Disorders and Stroke Notices of Special Interest Notice of Special Interest for Collaborative Activities to Enhance the Nanomaterials Health Implications Research (NHIR) Consortium Efforts (Admin Supp - Clinical Trial Not Allowed) (NOT-ES-19-013) National Institute of Environmental Health Sciences Notice of Special Interest: Administrative Supplements to Enhance Inclusion of Native Hawaiian/Other Pacific Islander Populations in Minority Health and Health Disparities Research(NOT-MD-19-023) National Institute on Minority Health and Health Disparities National Human Genome Research Institute Funding Opportunities PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed (PA-19-270) National Institutes of Health National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Neurological Disorders and Stroke National Institute of Nursing Research National Library of Medicine Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required (PA-19-271) National Institutes of Health National Center for Complementary and Integrative Health National Cancer Institute National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Nursing Research Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed (PA-19-272) National Institutes of Health Food and Drug Administration National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Center for Environmental Health National Cancer Institute National Center for Injury Prevention and Control National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Neurological Disorders and Stroke National Institute of Nursing Research National Institute for Occupational Safety and Health National Library of Medicine Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required (PA-19-273) National Institutes of Health National Center for Complementary and Integrative Health National Center for Environmental Health National Cancer Institute National Center for Injury Prevention and Control National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Nursing Research National Institute for Occupational Safety and Health Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Cognitive Systems Analysis of Alzheimer's Disease Genetic and Phenotypic Data (U01 Clinical Trial Not Allowed) (PAR-19-269) National Institute on Aging Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for this FOA is October 5, 2019. Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) (PAR-19-274) National Cancer Institute National Center for Complementary and Integrative Health National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Environmental Health Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Neurological Disorders and Stroke National Institute of Nursing Research Office of Behavioral and Social Science Research Office of Disease Prevention Office of Research on Women's Health Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) (PAR-19-275) National Cancer Institute John E. Fogarty International Center National Center for Complementary and Integrative Health National Human Genome Research Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institute of Nursing Research Office of Behavioral and Social Science Research Office of Disease Prevention Office of Research on Women's Health Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) (PAR-19-276) National Cancer Institute John E. Fogarty International Center National Human Genome Research Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke Office of Behavioral and Social Science Research Office of Disease Prevention Office of Research on Women's Health Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional) (PAR-19-277) National Cancer Institute Application Receipt Date(s): June 7, 2019; October 8, 2019; June 8, 2020; October 8, 2020; June 8, 2021; October 8, 2021 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) (PAR-19-278) National Institute on Drug Abuse Application Receipt Date(s): June 24, 2019, December 18, 2019, June 24, 2020, December 18, 2020, June 24, 2021, December 17, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Summer Research Training in Aging for Medical Students (T35 Clinical Trial Not Allowed) (RFA-AG-20-008) National Institute on Aging Application Receipt Date(s): July 22, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Lucidity in Dementia (R21 Clinical Trial Optional) (RFA-AG-20-016) National Institute on Aging Application Receipt Date(s): February 3, 2020, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on thisdate. Lucidity in Dementia (R21/R33 Clinical Trial Optional) (RFA-AG-20-017) National Institute on Aging Application Receipt Date(s): February 3, 2020, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on thisdate. Pragmatic Trials of Managing Multimorbidity in Alzheimer's Disease (R61/R33 Clinical Trial Required) (RFA-AG-20-029) National Institute on Aging Application Receipt Date(s): February 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Blockchain Technology to Improve SUD Care (R41/R42 - Clinical Trial Optional) (RFA-DA-20-011) National Institute on Drug Abuse Application Receipt Date(s): July 31, 2019, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Blockchain Technology to Improve SUD Care (R43/R44 - Clinical Trial Optional) (RFA-DA-20-012) National Institute on Drug Abuse Application Receipt Date(s): July 31, 2019, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act (U01) Clinical Trials Not Allowed (RFA-FD-19-026) Food and Drug Administration Application Receipt Date(s): July 10, 2019, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA. The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed) (RFA-GM-19-002) National Institute of General Medical Sciences Application Receipt Date(s): July 9, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Pediatric Critical Care Conferences Initiative (R13 Clinical Trial Not Allowed) (RFA-HD-20-012) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): July 31, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50)(RFA-NS-19-031) National Institute of Neurological Disorders and Stroke National Heart, Lung, and Blood Institute National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): October 31, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date